**Insilico Medicine Cayman TopCo Joins Hang Seng Composite Index**Insilico Medicine Cayman TopCo said it has been selected for inclusion in the Hang Seng Composite Index, effective March 9, 2026. The company added that the move is expected to help its shares meet eligibility criteria for trading via the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect
Reuters
Feb 20
**Insilico Medicine Cayman TopCo Joins <a href="https://laohu8.com/S/HSNGF">Hang Seng</a> Composite Index** Insilico Medicine Cayman TopCo said it has been selected for inclusion in the <a href="https://laohu8.com/S/HSNGY">Hang Seng</a> Composite Index, effective March 9, 2026. The company added that the move is expected to help its shares meet eligibility criteria for trading via the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect
Insilico Medicine Cayman TopCo said it will be **added** as a constituent of the **Hang Seng Composite Index** effective **March 9, 2026**. The company said the inclusion reflects the market’s recognition of its industry position, business performance and value, and is expected to improve share liquidity and broaden its investor base.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insilico Medicine Cayman Topco published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260220-12026422), on February 20, 2026, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.